Merih Kızıl Çakar

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Newly Diagnosed

Hodgkin Lymphoma

Top Venues

Journal of chemotherapy (Florence, Italy)

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Hikmettullah Batgi, Başcı Semih, Mehmet Sinan Dal, Merih Kızıl Çakar, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Nurgül Özcan, Ali Kılınç, Alparslan Merdin, Jale Yıldız, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Dicle İskender, Nuran Ahü Baysal, Fevzi Altuntaş
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience Turkish journal of medical sciences 51 (2) (2021)
Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden, Olga Meltem Akay Yanar, Özgür Mehta, Nurhilal Büyükkurt, Fehmi Hindilerden, Ahmet Kursad Gunes, Tuğçe Nur Yiğenoğlu, Başcı Semih, Merih Kızıl Çakar, Didar Yanardag Acik, Serdal Korkmaz, Turgay Ulas, Gülsüm Özet, Burhan Ferhanoğlu, Meliha Nalçacı, Fevzi Altuntaş
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of chemotherapy (Florence, Italy) (2021)